MIM launches medical imaging app for patients

Keith Moore | | Health Imaging | Screening
MIM Software’s VueMe App for iPad, iPhone and iPod touch is now available on the App Store.

This new app allows patients to view diagnostic images sent by their physicians, and to share these images, if needed, with specialists. The launch of VueMe comes on the heels of Mobile MIM, MIM Software's remote diagnostic imaging app for physicians.

Along with VueMe, MIM Software has also just released MIMcloud 2.0, an internet-based service designed to meet the needs of VueMe and Mobile MIM users. When using MIMcloud, all data are transferred and stored using secure encryption to ensure complete patient privacy.

The combination of the VueMe App and MIMcloud provides a way for patients to control their medical images. Patients have the right to request copies of their x-rays and other scans on a CD. The DICOM files can then be uploaded and transmitted to an iPad, iPhone or iPod touch using the MIMcloud software, according to the Cleveland-based provider of medical imaging software.

Keith Moore

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.